Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic.
The charts of all 561 patients (69% men and 31% women, mean age 71 +/- 10 years) with peripheral arterial disease (PAD) followed in an academic vascular surgery clinic were reviewed. Coexistent coronary artery disease (CAD) was present in 364 of 561 patients (65%). Of the 561 patients with PAD, 442 (79%) were current or exsmokers, 385 (69%) had hypertension, 225 (40%) had diabetes, 358 (64%) had a serum low-density lipoprotein (LDL) cholesterol > or =100 mg/dL, and 228 (41%) had a serum high-density lipoprotein cholesterol <40 mg/dL. Cilostazol or pentoxifylline was given to 301 of 301 patients (100%) with intermittent claudication. Aspirin or clopidogrel was given to 501 of 561 patients (89%) with PAD. Statins were given to 282 of 358 patients (79%) with PAD and an increased serum LDL cholesterol. If CAD was present, beta blockers were given to 301 of 364 patients (83%) and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers to 303 of 364 patients (83%).
Sukhija
Rishi
R
Department of Medicine, Cardiology Division, and the Division of Vascular Surgery, Westchester Medical Center/New York Medical College, Valhalla, New York 10595, USA.
Yalamanchili
Kiran
K
Aronow
Wilbert S
WS
Kakar
Priyanka
P
Babu
Sateesh
S
D000046:Academic Medical Centers; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000077407:Cilostazol; D003324:Coronary Artery Disease / Q000188:drug therapy*; D017723:Drug Utilization Review; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D008297:Male; D008485:Medical Audit; D008875:Middle Aged; D010431:Pentoxifylline / Q000627:therapeutic use*; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D012189:Retrospective Studies; D012307:Risk Factors; D013777:Tetrazoles / Q000627:therapeutic use*
D013777:Tetrazoles; D000077407:Cilostazol; D010431:Pentoxifylline